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The Common Cold:  What Pharmacists Need to Know 
Peggy Han, Pharm.D., Peggy McMillan, Pharm.D., Jeffery A. Goad, Pharm.D., BCPS 
University of Southern California, School of Pharmacy 
 
 Respiratory tract infections are the most common type of infectious disease in the 
United States, with the common cold being the second most frequent cause of this type of 
infection.1  Children under five years of age experience four to nine episodes of upper 
respiratory tract infections (URTI) per year, while children aged five to nine have an 
annual frequency of four to six episodes. Incidence of URTIs in children increase as they 
are exposed to more people, particularly other children in childcare facilities.2,3,4  Adults 
have fewer colds, only about one to two per year.  The morbidity associated with the 
common cold has a major impact on the health care budget.  The total costs associated 
with the common cold are estimated to be approximately $24 billion dollars per year.  
This includes both direct and indirect costs, such as expenditures for drugs or treatments 
to relieve symptoms, lost days of work, and decreased productivity.5  Specifically, an 
estimated 23 million days of work are lost each year, which is an average of almost 7 
days per person in the U.S.6 
 
Etiology 
 
 The leading cause of the common cold is the rhinovirus, which is responsible for 
more than 30% of all colds and consists of over 100 serotypes.  Additionally, coronavirus 
is the second leading cause of colds and accounts for about one-fifth of this type of 
infection.7,8  Influenza is another type of respiratory tract virus, but it is not a cause of the 
common cold.  Other viruses that cause cold symptoms include respiratory synctial virus 
(RSV) and parainfluenza.  In adults, these viruses often cause a mild self-limiting disease, 
but in infants with underlying pulmonary or cardiac problems, RSV can lead to death. 
Contrary to popular belief, a cold environment does not increase the risk of contracting 
the common cold.  Another common myth is that people with a weakened immune 
system are more likely to develop a cold compared to healthy people.  In fact, the 
opposite may be true.  Healthy people are more likely to be symptomatic from a cold 
because they can mount a better cytokine response than immunocompromised 
individuals. 
 
Pathophysiology 
 
 Modes of cold virus transmission include inhalation by airborne nasal droplets, 
ingestion of saliva directly or indirectly from sharing food or drink, and direct contact 
with an infected individual followed by rubbing the nose or eyes.  Smoking and 
psychologic stress may increase susceptibility to viral upper respiratory infections.  Once 
infected with a cold virus, individuals can be asymptomatic for approximately 48 to 72 
hours during the viral incubation period.  Although individuals may be asymptomatic 
during the incubation period, they may still be contagious. Inflammatory mediators, 
including histamine, kinins, and interleukins, are released in the nasal passages.  Host 
responses to these mediators cause rhinitis, nasal secretions, nasal congestion, sneezing, 
sore throat, and cough.  Nasal secretions may contain virus for up to one week after the 
overt symptoms of the cold are gone.9 
 Patient Assessment 
 
 The initial symptom of the common cold is generally a sore throat, followed by 
nasal symptoms, watering eyes, sneezing, and then cough.  These symptoms are usually 
self-limiting, and resolve within 1-2 weeks regardless of treatment.  The key to 
differentiating between a cold, the flu, and a bacterial infection is to assess the symptoms.  
(Table 1)  For example, an abrupt onset of fever and chills without sneezing or itchy eyes 
is most likely the flu.   
 
Treatment Options  
 
 Since there is no cure for the common cold, all treatment modalities are aimed at 
alleviating symptoms.  In addition to any pharmacologic treatment that is instituted, non-
pharmacologic measures should always be considered.  These include rest and 
maintaining adequate fluid intake.  Humidifiers or vaporizers may also be useful to 
alleviate symptoms.  (Table 2) 
 
Pharmacologic Treatment 
 
 When helping the patient select an appropriate product, the pharmacist should not 
overlook the value of the patient’s prior OTC use and experience.  Past product use may 
be obtained from the patient profile or a quick interview with the patient.  
 
Analgesics/Antipyretics – Fever, Sore Throat, Aches/Pains 
 
 While patients may complain of feeling feverish, high fevers are rarely seen in 
patients with the common cold, and, if a fever persists, the patient should be referred to a 
physician.  Some patients, however, may experience slightly elevated temperatures or 
mild myalgia, which may be relieved with OTC analgesics or antipyretics.  While all the 
OTC products are effective for these symptoms, the choice of acetaminophen, aspirin, or 
an NSAID depends on the age of the patient and the presence of any co-existing diseases 
or drug therapies.  For example, children should not take aspirin while they have a viral 
infection due to the potential for Reye’s Syndrome. 
 The irritated or sore throat that frequently accompanies the common cold may 
result from local inflammatory mediators.  Unless contraindicated, NSAIDS may be 
preferred over acetaminophen or regular dose aspirin. In patients with colds, 
experimental evidence suggests that acetaminophen and aspirin lower serum neutralizing 
antibody titers and increase the duration of viral shedding in nasal secretions.10  In 
addition, OTC lozenges, gargles, and sprays containing topical anesthetics, such as 
benzocaine, dyclonine, and phenol, may be used every 3-4 hours for temporary, 
symptomatic relief of a sore throat.  
 
Decongestants – Nasal/Ocular Congestion 
  
 Decongestants are the mainstay of treatment for the common cold. They are 
alpha-adrenergic agonists which constrict blood vessels throughout the body, particularly 
the nasal and ocular vasculature.   
Decongestants may be given orally or topically, including both intranasal and 
ophthalmic preparations (Table 2).  Topical decongestants are minimally absorbed, 
decreasing the incidence of systemic side effects. Drainage into the stomach may occur 
when excess drops are applied to the nose (nasopharynx to the stomach) or eyes 
(nasolacrimal duct to the nasopharynx to the stomach), resulting in systemic absorption.  
Rebound congestion (Rhinitis Medicamentosa), manifesting as increased nasal 
congestion after decongestant cessation, may occur after only three days of use.  This 
phenomenon is more common with shorter acting topical decongestants than longer 
acting agents.   
Systemic decongestants, such as pseudoephedrine and phenylpropanolamine, 
constrict the alpha adrenergic vascular beds and stimulate the central nervous system.  
Cardiac side effects include increased blood pressure, increased heart rate, and 
palpitations.  Nervousness, irritability, restlessness, and insomnia may also occur.  
Diseases potentially aggravated by decongestants include high blood pressure, heart 
disease, diabetes mellitus, hyperthyroidism, benign prostatic hyperplasia, and angle-
closure glaucoma.  In addition, decongestants are contraindicated in patients taking 
monoamine oxidase inhibitors (MAOIs), which may further intensify the alpha-
adrenergic effects of the decongestants.  Therefore, when selecting a decongestant, 
pharmacists should question patients about the presence of concomitant diseases and the 
use of other medications.  An understanding of decongestant effects on various organ 
systems will aid in determining precautions and contraindications (Table 3).   
 The OTC decongestants are all Category C agents and, therefore, should be used 
during pregnancy only if the potential benefit justifies the potential risk to the fetus. 
Additionally, lactating women should use decongestants with caution since it is unknown 
how much is excreted into breast milk following topical or systemic administration.11 
Topical saline drops are very safe and may be used in place of topical decongestants in 
pregnancy, lactation, and in infancy. 
 
Expectorants/Mucolytics/Antitussives - Cough 
 
 The common cold can cause either a dry, hacking cough or a productive cough 
that results in the expectoration of sputum.  A productive cough is the mechanism by 
which the body clears the lungs and airways of unwanted materials.   
 Nonprescription cough products contain expectorants, such as guaifenesin, or 
cough suppressants, such as dextromethorphan.  Expectorants may thin sputum, increase 
volume, and facilitate expulsion. Guaifenesin is thought to expel respiratory tract 
secretions by reflex gastric stimulation.  In 1992, the FDA warned against the use of OTC 
expectorants in children under 12 years of age if there is a persistent or chronic cough, 
such as occurs with asthma, or if the cough is accompanied by excessive mucus.  The key 
to successful use of guaifenesin is to drink plenty of fluids to lower the viscosity of the 
sputum and aid in expectoration. 
 Antitussives, which inhibit or suppress the act of coughing, are most effective for 
dry coughs.  Centrally acting agents suppress the medullary centers of the brain, decrease 
the sensitivity of respiratory system cough receptors, or interrupt the transmission of 
cough impulses.  If they are given to a patient with a productive cough, more mucus is 
retained and may ultimately result in pneumonia.12  Dextromethorphan, an isomer of 
levorphanol, is generally well tolerated at therapeutic dosages, however drowsiness and 
GI upset may occur.  While at recommended doses addiction potential is low, doses 
exceeding 120 mg can result euphoria with bizarre behavior as a result of its opiate and 
phencyclidine (PCP) activities.13 In addition, concomitant use with monoamine oxidase 
inhibitors is not recommended due to the potential for hypertensive crisis.   
 
Zinc 
 
One of the most controversial and popular natural remedies for the common cold 
is zinc.  Zinc lozenges and lollipops are widely available in pharmacies and 
supermarkets.  Of ten randomized, controlled studies of zinc lozenges for the common 
cold, five showed positive results and five showed negative results.14  The exact 
mechanism of action of zinc is unclear, but it may inhibit viral binding to epithelial cells 
in the upper respiratory tract 
 Past clinical trials do not consistently support the efficacy of zinc gluconate 
lozenges to treat the common cold.  The formulation of the lozenge, though, appears to be 
important because the addition of citric acid or tartaric acid in some preparations may 
actually reduce efficacy by chelating the zinc ion.15  The benefit appears to be maximal if 
the lozenges are started immediately after the onset of symptoms.  Common side effects 
include unpleasant taste, mouth irritation and nausea.  Patients should be instructed to 
take one lozenge every 2 hours while awake and continue for the duration of the illness.  
To minimize the incidence of nausea, the lozenges should not be taken on an empty 
stomach.  Additionally, citrus containing juices should be avoided within an hour of 
taking a lozenge to reduce the possibility of chelation of zinc ions.15   
 If a patient decides to use zinc, the pharmacist should advise the patient on 
conventional OTC medications that are effective for symptom management.  Pediatric 
use should be discouraged until more information on safety and efficacy are available.  
Common OTC products containing zinc include Cold-Eeze and Zicam.   
 
Vitamin C 
 
 The use of vitamin C to prevent or treat the common cold remains a controversial 
topic.  The proposed mechanism of action is that vitamin C, an antioxidant, neutralizes 
the large amounts of oxidizing compounds released by neutrophils.  An extensive review 
of 61 trials published between 1940 and 1991 concluded that vitamin C, even in gram 
doses per day, cannot prevent a cold.16  However, it has been suggested that large doses, 
1-4 grams per day, may decrease the duration and severity of symptoms by 10-29%.17  
The patient should be cautioned that large doses of ascorbic acid could lead to diarrhea 
and renal stones. 
 
 Herbals 
 
 Herbal products have recently gained increasing interest with the public as a 
remedy for the common cold.  Studies of efficacy using double-blind, placebo-controlled 
methods are rare.  However, some of the more widely used products will be studied in the 
near future under the sponsorship of the National Institutes of Health.  (Table 4) 
 
Homeopathy 
 
Homeopathy is based on the theory similars.  For example, large doses of drugs 
that produce symptoms of a disease in healthy people will cure the same symptoms when 
administered in extremely small amounts.18  After the many dilutions required for 
potency, these products probably contain no measurable active ingredient.  Although 
some studies report positive findings, well-designed, clinical trials have yet to be 
conducted.19  The lack of valid clinical evidence has not deterred the public from 
purchasing these products to the tune of millions per year.  One popular product is 
oscillococcinum 
 Oscillococcinum is a common remedy used by practitioners of homeopathic 
medicine as well as the public for the treatment of symptoms of the common cold and flu.  
It contains extremely diluted constituents of autolysed duck heart and liver with literally 
no “active” ingredient detectable.19,20  One placebo-controlled study conducted in France 
in patients with influenza-like symptoms demonstrated a significantly greater number of 
patients recovering within 48 hours after initiation of oscillococcinum compared to 
placebo.  However, this study was significantly flawed by multiple factors, rendering the 
results useless.20  
 
Future 
 
Current drug therapy is aimed at ameliorating the symptoms of the cold, not eliminating 
the causative virus. Pleconaril is a new investigational antiviral drug with activity against 
picornoviruses, including rhinoviruses and enteroviruses, a cause of viral meningitis.21 
Initial trials of Pleconaril versus the common cold did not demonstrate a dramatic 
decrease in cold symptoms, but subsequent trials may show otherwise.   
 
Conclusion 
 
 Despite the numerous OTC products available for symptomatic treatment of the 
common cold, a definitive cure remains to be discovered.  Supportive care remains the 
mainstay of therapy.  Therefore, as pharmacists, it is important that we assess each 
patient individually, taking into account other disease states and current drug therapy, as 
we target our counseling and recommendations to the individual’s specific symptoms.  
(Table 5)   
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Table 1  Influenza vs. Common Cold vs. Bacterial Infection  
 
Characteristic Influenza Common Cold Bacterial 
Presentation Generalized Local-nose & throat Systemic 
Onset Sudden Gradual Gradual-sudden 
Fever High (>100F) Mild High (>100F) 
Differential 
symptoms 
Headache 
Chills 
Muscle pains 
Nonproductive Cough 
Sore throat 
Anorexia 
Sneezing  
Nasal congestion 
Sore throat 
Productive cough 
Chills  
Chest pain 
Productive cough 
Tachycardia 
Tachypnea 
Fatigue, 
weakness, & 
exhaustion 
Extreme Mild Extreme 
Duration 1-5 days high fever; 1-
3 weeks symptoms 
1 week; rapid 
recovery 
variable 
Complications Pneumonia; bronchitis  Earache Sepsis 
 
  
Table 2  Symptomatic OTC Treatment of the Common Cold  
 
Symptom Treatment 
Nasal congestion and discharge Decongestants 
 Systemic 
  Ephedrine 
Phenylephrine 
Phenylpropanolamine 
Pseudoephedrine 
Inhalers 
Desoxyephedrine 
Propylhexedrine 
 Topical (duration) 
Short Acting (4-6 hours) 
Ephedrine 
Epinephrine 
Naphazoline 
Phenylephrine 
Tetrahydrazoline 
Intermediate Acting (8-10 hours) 
Xylometazoline 
Long Acting  
Oxymetazoline 
 Ophthalmic 
Epinephrine 
Naphazoline 
Oxymetazoline 
Phenylephrine 
Tetrahydrazoline 
Cough Hydration 
Antitussives 
Expectorants 
Cool mist/steam vapors 
Sore throat Saline gargles 
Local anesthetics 
Systemic analgesics 
Feverishness and headache Systemic analgesics 
Adapted from reference 23 
 
 
 
 
 Table 3  Adverse Effects and Potential Contraindications of Decongestants  
 
Target Symptoms Systemic Effects Adverse Effects Potential 
Contraindications 
Blood vessels Constricts Hypertension Hypertensive     
  patients  
MAOI use within  
  past 2 weeks 
Heart Stimulates Tachycardia Arrhythmia  
Cardiovascular     
  disease 
Eye Constricts radial 
muscle 
Increase intraocular 
pressure 
Glaucoma 
Genitourinary 
tract 
Constricts bladder 
sphincter 
Obstructs urinary 
flow 
BPH 
Exocrine glands Stimulates Hyperthyroidism 
Hyperglycemia 
Hyperthyroidism 
Diabetes 
Central nervous 
system 
Stimulates Excitability Seizures 
 
 
 
 Table 4  Herbal Products 
 
Herb Use Clinical Considerations 
Echinacea Supportive therapy for 
colds and chronic infections 
of the respiratory tract; 
immunostimulant 
 Cross sensitivity in 
patients allergic to 
sunflower seeds  
 Caution in patients with 
autoimmune disease, 
AIDS, or leukemia 
because of T-cell and 
macrophage stimulation 
 Not recommended for 
chronic use 
Ephedra (Ma Huang) Bronchial asthma (produces 
bronchodilation, 
vasoconstriction, and 
reductions in bronchial 
edema) 
 Avoid in patients with 
cardiac conditions, 
HTN, diabetes, or 
thyroid disease 
 Side effects:  
nervousness, insomnia, 
palpitation 
 Avoid concomitant use 
with decongestants, 
weight control products 
Goldenseal Antimicrobial, astringent, 
and antihemorrhagic 
activity in the treatment of 
mucosal inflammation 
 Absolute 
Contraindicated in 
pregnancy 
Horehound Expectorant, antitussive  FDA declared 
ineffective as a cough 
suppressant and 
expectorant 
Adapted from reference 22 
 
 
  
Table 5  Patient Counseling Tips  
 
 Select medications that treat only the symptoms you have. 
 Don’t take medicines longer or in higher doses than the label recommends.  If 
symptoms persist, see a physician. 
 If the label says use two teaspoons, use a measuring spoon, or a dosing cup marked in 
teaspoons, or an oral syringe, instead of a common kitchen spoon. 
 Find out if the patient has other medical conditions (diabetes, hypertension, 
hyperthyroidism) or is currently taking any prescription or nonprescription 
medications that should be considered in selecting a product. 
 Determine what products have been tried and the outcome of prior therapy. 
 Select a product that is most convenient for the patient to take to enhance compliance. 
 
